SS&C Intralinks Success Stories
We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.
Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.
USD 900 million
African Development Partners III is the firm's third growth fund dedicated to investments in companies serving Africa's middle class.
USD 1.89 billion
Eurazeo Growth Fund III will assist fast-growing companies in technology sectors by setting up the necessary financial and human resources for their development and the completion of transformation projects.
USD 100 million
Oriens Capital Private Equity Fund 2 is the second fund in its series. The fund focuses on mid-market opportunities in regional New Zealand.
£$275 million
True Capital seeks to invest in UK-headquartered, lower-mid market businesses operating in the consumer products and services sector.
€472 million
Sofinnova Capital X is a venture capital fund investing into in early-stage healthcare companies in the biopharmaceutical and medical device industries in Europe.
€225 million
Singular is an early stage fund investing in European companies operating within a diversified range of sectors..
€455 million
Oakley Capital Origin is a fund managed by Oakley Capital Private Equity. The fund invests in a wide range of industries
€1.25 billion
Providence Strategic Growth Europe seeks investments in lower middle market software and technology-enabled service companies. The fund will invest 90-95% in Western Europe.
€856 million
Naxicap Investment Opportunities II invests in SMEs that show high internal, or build-up growth potential, in both France and Europe.
€180 million
Mill Reef Capital Fund SCS is a secondaries fund advised by Mill Reef Capital and targets investment opportunities across Europe.
€1.3 billion
mcp Opportunity Secondary Program Fund V is the fifth vehicle raised by Montana Capital Partners and will follow a similar strategy to its predecessors, by completing small and more complex secondary transactions.
kr914 million
Idekapital Fund II is a fund managed by Idekapital which invests on growing Norwegian technology companies.
€2 billion
GHO Capital Fund III is the firm's third buyout vehicle that focuses on mid-market buyout and growth opportunities in the healthcare sector.
€155 million
Digital Health 2 is a venture capital vehicle that targets SMEs in commercial phase operating in the digital health industry.
EUR€650 million
EMH Growth Fund II invests growth capital in technology-enabled companies in Europe.